refractory, locally advanced Non small cell lung cancer
refractory, locally advanced Non small cell lung cancer is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.
- Also known as
- refractory, locally advanced Non-small cell lung cancer
- Classified under
What you can answer from here — as of October 07, 2026
2Indicated drugsWith each drug's targets and mechanismListed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for refractory, locally advanced Non small cell lung cancer share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account